Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
548.40
-7.8 (-1.4%)
BSENSE

Nov 20

BSE+NSE Vol: 1.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10038977,
    "name": "Concord Biotech",
    "stock_name": "Concord Biotech",
    "full_name": "Concord Biotech Ltd",
    "name_url": "stocks-analysis/concord-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "548.40",
    "chg": -7.8,
    "chgp": "-1.4%",
    "dir": -1,
    "prev_price": "556.20",
    "mcapval": "11,580.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543960,
    "symbol": "CONCORDBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE338H01029",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.38 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/concord-biotech-10038977-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Concord Biotech Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-4270007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ConcordBiotechL_mojoScore_4270007.png",
        "date": "2026-11-21 10:10:33",
        "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Concord Biotech Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-4257222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ConcordBiotechL_mojoScore_4257222.png",
        "date": "2026-11-10 10:10:43",
        "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Concord Biotech Gains 1.53%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/concord-biotech-gains-153-4-key-factors-driving-the-weeks-volatility-4254990",
        "imagepath": "",
        "date": "2026-11-07 11:02:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Sharp 6.53% decline amid technical downshift</p>\n                    <p><strong>3 Nov:</strong> Recovery with 5.66% gain following bearish signals</p>\n                    <p><strong>4 Nov:</strong> Intraday high surge of 7.02%, outperforming sector</p>\n                    <p><strong>6 Nov:</strong> Intraday low and 6.25% drop despite positive market</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.622.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.632.15</div><di..."
      },
      {
        "title": "Concord Biotech Ltd Hits Intraday Low Amid Price Pressure on 6 Nov 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/concord-biotech-ltd-hits-intraday-low-amid-price-pressure-on-6-nov-2026-4254212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ConcordBiotechL_priceRelatedfactors_4254212.png",
        "date": "2026-11-06 11:31:46",
        "description": "Concord Biotech Ltd experienced a notable intraday decline on 6 Nov 2026, with the stock touching a low of Rs 628, reflecting a 6.87% drop from its previous close. This downturn occurred despite a broadly positive market environment, as the Sensex advanced by 0.6% during the session."
      },
      {
        "title": "Concord Biotech Ltd Surges 7.02% to Day's High of Rs 661.9 — Outperforms Sector by 6.83 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/concord-biotech-ltd-hits-intraday-high-with-702-surge-on-4-nov-2026-4250927",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ConcordBiotechL_priceRelatedfactors_4250927.png",
        "date": "2026-11-04 14:38:39",
        "description": "The Sensex rose 0.37% on 04 Nov 2026, but Concord Biotech Ltd outpaced the broader market with a 7.02% gain, reaching an intraday high of Rs 661.9. This 6.83 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Concord Biotech Gains 1.34%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/concord-biotech-gains-134-3-key-factors-driving-the-weeks-volatility-4245573",
        "imagepath": "",
        "date": "2026-10-31 11:01:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Intraday high surge to Rs.1,319 (+7.34%)</p>\n                    <p><strong>27 Oct:</strong> Technical momentum shifts with 6.30% gain</p>\n                    <p><strong>28 Oct:</strong> Shares hit intraday low amid 7.66% decline</p>\n                    <p><strong>30 Oct:</strong> Week closes at Rs.1,245.30 (+1.25% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,228.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,245.30</div><div class=\"stat-change p..."
      },
      {
        "title": "Concord Biotech Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-4244429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ConcordBiotechL_mojoScore_4244429.png",
        "date": "2026-10-30 10:11:10",
        "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Concord Biotech Ltd Surges 7.34% to Day's High of Rs 1319 — Outperforms Sector by 6.16 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/concord-biotech-ltd-hits-intraday-high-with-734-surge-on-26-oct-2026-4239766",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ConcordBiotechL_priceRelatedfactors_4239766.png",
        "date": "2026-10-26 15:48:31",
        "description": "The Sensex rose 0.66% on 26 Oct 2026, but Concord Biotech Ltd outpaced the broader market with a 7.34% gain, touching an intraday high of Rs 1319. This 6.16 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Concord Biotech Ltd Faces Technical Downgrade Amid Bearish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/concord-biotech-ltd-faces-technical-downgrade-amid-bearish-momentum-4231483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/ConcordBiotechL_technicaldot_4231483.png",
        "date": "2026-10-21 08:08:13",
        "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from sideways trading to a mildly bearish trend. Recent technical indicators including MACD, RSI, and moving averages reveal a complex picture of weakening price momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 5 October 2026."
      }
    ],
    "total": 77,
    "sid": "10038977",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/concord-biotech-10038977"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "05-Nov-2026",
      "details": "Intimation of allotment of Bonus equity Shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Nov-2026",
      "details": "Transcript of Q2 - FY27 Earnings call held on October 28 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-Oct-2026",
      "details": "Press release - For the Second quarter and half year ended on September 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Concord Biotech Ltd has declared <strong>755%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Concord Biotech Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 04 Nov 26",
          "dt": "2026-11-04",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Allotment

05-Nov-2026 | Source : BSE

Intimation of allotment of Bonus equity Shares

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

03-Nov-2026 | Source : BSE

Transcript of Q2 - FY27 Earnings call held on October 28 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

28-Oct-2026 | Source : BSE

Press release - For the Second quarter and half year ended on September 30 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Concord Biotech Ltd has declared 755% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Concord Biotech Ltd has announced 1:1 bonus issue, ex-date: 04 Nov 26

stock-summary
RIGHTS

No Rights history available